Harbin Gloria Pharmaceuticals Co.,Ltd.



Quote for Harbin Gloria Pharmaceuticals Co.,Ltd.

Last Trade:
-
Change:
--
Symbol/Code:
002437
Status:
-
Stock Type:
A Share
Market Cap:
-
Open:
-
Prev Close:
-
Bid:
-
Ask:
-
Volume(*100):
-
Amount:
-
Limit Up:
-
Limit Down:
-
Day's Range:
-
P/E(ttm):
-
P/B ratio
-
Update:-
Currency in CNY Time=UTC+8002437 quote

Summary for Harbin Gloria Pharmaceuticals Co.,Ltd.

HARBIN GLORIA PHARMACEUTICALS Co., LTD. is principally engaged in the manufacture and distribution of pharmaceuticals. The Company mainly provides injections, include drugs for orthopedic diseases, drugs for gynecological diseases, drugs for cardiovascular and cerebrovascular diseases, anti-tumor drugs, stop bleeding drugs and antibiotics, among others, such as cervus and cucumis polypeptide for injection, gemcitabine hydrochloride for injection, cefaclor capsules, gatifloxacin for injection, aceglutamide for injection and L-carnitine for injection, among others. The Company also involves in the agent distribution of pharmaceuticals, such as alprostadil fat emulsion injection and deoxyribonucleic acid (DNA) injection. The Company operates its businesses primarily in domestic markets.

Profile for Harbin Gloria Pharmaceuticals Co.,Ltd.

Full Name:Harbin Gloria Pharmaceuticals Co.,Ltd.
Full Name in Chinese:哈尔滨誉衡药业股份有限公司 Short Name in Chinese:誉衡药业
Symbol/Stock Code:
002437
Listed in:
Shenzhen Stock Exchange
Issued Capital
-
Negotiable Capital:
-
Chairman:
Zhu Jiman
Secretary of the Board:
Yu Tianxun
Phone:
+86-010-68002437
Fax:
+86-010-68002438-607
Official Website:www.gloria.cc
E-mail:gloriapharma@126.com
Address:Building 28,Limin Economic and Technologic,BEIJING BEJ 100070
IPO Subscription Date:
2010-06-07
Listing Date:
2010-06-23
IPO Issued Capital:
35000000
IPO Price:
50 CNY
IPO fees:
81468400 CNY
Money Raised by IPO:
1750000000 CNY
IPO Par Value:
1.00 CNY
Net Money Raised:
1668531600 CNY
Open(Listing day):
55.00 CNY
Close(Listing day):
59.33 CNY
Diluted P/E ratio after IPO:
54.3500
Turnover rate(listing day):
84.40%

Financials for Harbin Gloria Pharmaceuticals Co.,Ltd.

UPDATE:2012-10-28 Annual Report Abstract:(All Currency In CNY)

Indicators/Till The Date
2012-09-30
2011-12-31
2010-12-31
2009-12-31
Net Profit(after tax)(Million)
99.2464
116.8483
154.713
130.2351
Net Profit Growth(%)
31.44
-24.47
18.79
22.92
Return On Equity(ROE)(%)
4.38
5.39
7.30
45.29
Debt ratio(%)
10.01
4.96
3.35
35.01
Net Operating Cash Flow/Net Profit(%)
176.74
110.06
72.78
131.16

Per Share Financial Data:(All Currency In CNY)

Per Share Indicators/Till The Date
2012-09-30
2011-12-31
2010-12-31
2009-12-31
Earnings Per Share(EPS)
0.3500
0.4200
0.6300
1.2400
Diluted Earnings Per Share
0.0000
0.3600
0.6600
1.2300
Net Asset Value Per Share (NAVPS)
8.1000
7.7400
15.1500
2.7400
Additional Paid-In Capital Per Share
5.3870
5.3870
11.7705
0.0416
Retained Earnings Per Share
1.5236
1.1692
2.1225
1.4747
Net Cash Flow From Operatings Activities Per Share
0.6300
0.4600
0.4600
1.6300
Net Cash Flow Per Share
-0.4634
-0.3100
10.3597
0.4350

Balance Sheet:(All Currency In CNY)

Assets And Liabilities/Till The Date
2012-09-30
2011-12-31
2010-12-31
2009-12-31
Total Assets(Million)
2551.1836
2312.2536
2194.47
442.4769
Total Liabilities(Million)
255.5472
114.9073
73.7276
154.9475
Current Liabilities(Million)
226.6512
81.2738
73.7276
154.9475
Long Term Liabilities(Million)
-
-
-
-
Cash And Cash Equivalents(Million)
1323.7662
1453.5226
1538.3226
87.9655
Accounts Receivables(Million)
38.4144
3.1881
18.221
0.7239
Deposit Received(Million)
5.4555
2.1843
3.8313
2.9977
Other Receivables(Million)
97.2368
66.9975
76.7992
46.8668
Bad Debt Reserve(Million)
-
-
-
-
Shareholder's Equity/Owner's Equity(Million)
2267.3371
2168.0907
2120.7425
287.5294
Debt ratio(%)
10.01
4.96
3.35
35.01
Equity Ratio(%)
88.8700
93.7600
96.6400
64.9800
Current Ratio
8.6408
22.3854
24.8950
1.4933
Quick Ratio
8.2701
21.4937
24.1725
1.3412

Cash Flow Statement:(All Currency In CNY)

Cash Flow/Till The Date
2012-09-30
2011-12-31
2010-12-31
2009-12-31
Cash From Selling Commodities(Million)
642.0035
641.2539
657.8344
518.3011
Net Cash Flow From Operatings Activities(Million)
175.4105
128.6069
112.5925
170.815
Net Cash Flow From Operatings Activities Change(%)
333.16
14.22
-34.09
195.48
Net Cash Flow(Million)
-129.7564
-86.8
1450.3571
45.6786
Cash From Selling Commodities/Prime Revenue(%)
138.99
117.37
114.32
120.56
Net Cash Flow/Net Profit(%)
-130.74
-74.28
937.45
35.07
Cash Flow From Investing Activities(Million)
-340.1823
-180.0888
-240.8789
-124.5203
Cash Flow From Financing Activities(Million)
35.0154
-35.3203
1578.6423
-0.6162

Income Statement:(All Currency In CNY)

Income Indicators/Till The Date
2012-09-30
2011-12-31
2010-12-31
2009-12-31
Prime Operating Revenue(Million)
461.914
546.3645
575.4484
429.929
Prime Operating Profit(Million)
-
-
-
-
Operating Costs(Million)
88.8791
51.7106
55.8109
50.1842
Administrative Costs(Million)
87.5882
98.1049
65.4089
32.7964
Financing Costs(Million)
-22.9905
-27.25
0.552
3.84
Above Three Costs Change(%)
80.85
0.65
40.26
31.40
Operating Profit(Million)
120.9348
138.6306
181.2101
151.7362
Income From Investment(Million)
2.726
-1.1128
-1.431
-0.4178
Government Subsidies(Million)
-
-
-
-
Net Non-Operating Income And Expense(Million)
-0.0622
-2.1249
1.8512
1.1812
Total Profit(Million)
120.8726
136.5056
183.0613
152.9174
Corporate Income Tax(Million)
22.5824
20.0001
28.3483
22.6823
Net Profit(Million)
99.2464
116.8483
154.713
130.2351
Gross Profit Ratio(%)
60.73
48.63
53.21
56.42
Operating Margin(%)
26.18
25.37
31.49
35.29
Return On Equity(ROE)(%)
4.38
5.39
7.30
45.29

Announcements for Harbin Gloria Pharmaceuticals Co.,Ltd.

Date: 2012-10-29
Title: EGM-SPOT
The Company will hold the 1st Extraordinary General Meeting of 2012 at 10:00 on 15 November 2012.

Meeting agenda:
1. Nomination of Liu Chang as director
2. Formulation of the profit distribution management system
3. Amendments to the Company's articles of association(June, 2012 Version)
4. Amendments to the Company's articles of association(October, 2012 Version)


Meeting attendees:
1. A-share holders registered at CSDCC Shenzhen after the close of trading on 12 November 2012 are entitled to vote. Original notarized power of attorney for voting is required.
2. Directors of the board, supervisors of the supervisory committee, senior executives and appointed lawyers are entitled to attend the meeting.

Registration period: from 13 November 2012 to 13 November 2012
Date: 2012-04-24
Title: AGM RESOLUTION
The Company held its Annual General Meeting of 2011 on 23 April 2012, during which the following proposal(s) was/were approved:
1. 2011 annual report and its summary
2. 2011 work report of the board of directors and 2011 work report of independent directors
3. 2011 work report of the supervisory committee
4. 2011 financial resolution report
5. 2011 profit distribution plan
6. Reappointment of 2012 external audit firm
7. Nomination of Ms He Liqun and Ms Yu Tianxun as director
8. Issue of corporate bonds
9. Mandate to the board to handle matters in relation to the issue of corporate bonds
10. Repayment guarantee measures for the issue of corporate bonds
The detailed profit distribution plan are as follows:
1) Cash dividend/10 shares (tax included): CNY0.00000000
2) Bonus issue from profit (share/10 shares): none
3) Bonus issue from capital reserve (share/10 shares): none.
Date: 2012-04-12
Title: AGM CHANGE
Further to our previous message on 22 March 2012 about the Company's Annual General Meeting of 2011, the Company announced on 12 April 2012 the following changes made with regard to the said meeting:

Change in relevant item(s):
1) End Date for Online Voting via the Internet:20120423
2) Start Date for Online Voting via the Internet:20120422
3) Voting Date via the Trading System:20120423
Additional items to be discussed:
1. Issue of corporate bonds
2. Mandate to the board to handle matters in relation to the issue of corporate bonds
3. Repayment guarantee measures for the issue of corporate bonds
Other information remains unchanged.
Date: 2012-03-22
Title: FINAL DIVIDEND
The Company issued its 2011 annual report on 22 March 2012.

The profit distribution proposal for 2011:
1. Cash dividend/10 shares (tax included): CNY0.00000000
2. Bonus issue from profit (share/10 shares):none
3. Bonus issue from capital reserve (share/10 shares):none.
Date: 2012-03-22
Title: AGM-SPOT
The Company will hold the 2011 Annual General Meeting at 10:00 on 23 April 2012.

Meeting agenda:
1. 2011 annual report and its summary
2. 2011 work report of the board of directors and 2011 work report of independent directors
3. 2011 work report of the supervisory committee
4. 2011 financial resolution report
5. 2011 profit distribution plan
6. Reappointment of 2012 external audit firm
7. Nomination of Ms He Liqun and Ms Yu Tianxun as director
The detailed profit distribution plan are as follows:
1) Cash dividend/10 shares (tax included): CNY0.00000000
2) Bonus issue from profit (share/10 shares): none
3) Bonus issue from capital reserve (share/10 shares): none

Meeting attendees:
1. A-share holders registered at CSDCC Shenzhen after the close of trading on 17 April 2012 are entitled to vote. Original notarized power of attorney for voting is required.
2. Directors of the board, supervisors of the supervisory committee, senior executives and appointed lawyers are entitled to attend the meeting.

Registration period: 18 April 2012
Date: 2011-06-22
Title: RESTRICTED SHARE LISTING
THE CO'S 25200000 RESTRICTED A-SHARES WILL BE LISTED ON THE SHENZHEN STOCK EXCHANGE AS OF 23JUN11.
Date: 2011-06-17
Title: EGM RESOLUTION
THE CO HELD ITS 3RD EGM OF 2011 ON 16JUN11, DURING WHICH THE FOLLOWING PROPOSAL(S) WAS/WERE APPROVED:
1. FORMULATION OF THE RULES FOR IMPLEMENTATION OF ACCUMULATIVE VOTING
2. NOMINATION OF NON INDEPENDENT DIRECTOR CANDIDATES INCLUDING ZHU JIMAN, WANG DONGXU, YANG HONGBING, LENG GUOQING, YANG HUARONG, ZHANG GUIRONG
3. NOMINATION OF INDEPENDENT DIRECTOR CANDIDATES INCLUDING DONG QI, ZHAO ZHONGQIU, XU XIAOGE
4. ELECTION OF SUPERVISORS INCLUDING BAI LIHUI, CHENG GENQIANG
Date: 2011-06-01
Title: EGM-SPOT
THE CO WILL HOLD THE 3RD EGM OF 2011 AT 09:00 ON 16JUN11.

MEETING AGENDA:
1. FORMULATION OF THE RULES FOR IMPLEMENTATION OF ACCUMULATIVE VOTING
2. NOMINATION OF NON INDEPENDENT DIRECTOR CANDIDATES INCLUDING ZHU JIMAN, WANG DONGXU, YANG HONGBING, LENG GUOQING, YANG HUARONG, ZHANG GUIRONG
3. NOMINATION OF INDEPENDENT DIRECTOR CANDIDATES INCLUDING DONG QI, ZHAO ZHONGQIU, XU XIAOGE
4. ELECTION OF SUPERVISORS INCLUDING BAI LIHUI, CHENG GENQIANG

MEETING ATTENDEES:
1. A-SHARE HOLDERS REGISTERED AT CSDCC SZN AFTER THE CLOSE OF TRADING ON 09JUN11 ARE ENTITLED TO VOTE. ORIGINAL NOTARIZED POWER OF ATTORNEY FOR VOTING IS REQUIRED.
2. DIRECTORS OF THE BOARD, SUPERVISORS OF THE SUPERVISORY COMMITTEE, SENIOR EXECUTIVES AND APPOINTED LAWYERS ARE ENTITLED TO ATTEND THE MEETING.

REGISTRATION PERIOD: 10JUN11
Date: 2011-05-31
Title: EGM RESOLUTION
THE CO HELD ITS 2ND EGM OF 2011 ON 30MAY11, DURING WHICH THE FOLLOWING PROPOSAL(S) WAS/WERE APPROVED:
1. AMENDMENTS TO THE CO'S ARTICLES OF ASSOCIATION AND CHANGES IN THE INDUSTRIAL AND COMMERCIAL REGISTEATION
Date: 2011-05-11
Title: EGM-SPOT
THE CO WILL HOLD THE 2ND EGM OF 2011 AT 09:00 ON 30MAY11.

MEETING AGENDA:
1. AMENDMENTS TO THE CO'S ARTICLES OF ASSOCIATION AND CHANGES IN THE INDUSTRIAL AND COMMERCIAL REGISTEATION

MEETING ATTENDEES:
1. A-SHARE HOLDERS REGISTERED AT CSDCC SZN AFTER THE CLOSE OF TRADING ON 23MAY11 ARE ENTITLED TO VOTE. ORIGINAL NOTARIZED POWER OF ATTORNEY FOR VOTING IS REQUIRED.
2. DIRECTORS OF THE BOARD, SUPERVISORS OF THE SUPERVISORY COMMITTEE, SENIOR EXECUTIVES AND APPOINTED LAWYERS ARE ENTITLED TO ATTEND THE MEETING.

REGISTRATION PERIOD: 25MAY11